Search Results

A Phase 2b, Open-Label, Two-cohort Study of Subcutaneous Amivantamab in Combination with Lazertinib as First-Line Treatment, or Subcutaneous Amivantamab in Combination with Platinum-Based Chemotherapy as Second-line Treatment, for Common EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (COPERNICUS) (61186372NSC2012) MOA: Subcutaneous amivantamab is a bispecific ab against EGF and cMET receptors, that is co-formulated with…

Ariuka Arya is a nurse practitioner with over six years of experience as a registered nurse across adult ICU, trauma, and cardiac testing settings. She received her Bachelor of Science in Nursing from George Mason University and her Master of Science in Nursing as a family nurse practitioner from the University of Alabama at Birmingham.…

Eileen Byrne, MSN, CRNP, is a nurse practitioner at Maryland Oncology Hematology. Eileen earned her Bachelor of Science in Nursing from Georgetown University before completing a Master of Science in Nursing at the University of Pennsylvania. She worked in oncology nursing for six years prior to joining the team at Maryland Oncology Hematology. Eileen has…

Mature cancer care patient Tremendous advances are made every day in the fight against cancer, but many promising treatments are costly, placing patients under enormous financial pressure. The challenges of increasing premiums, deductibles, and copayments affect many, with up to 61% of cancer patients facing difficulties in their care.1 Patients in Maryland Have a Choice in Cancer…